2022 Annual Meeting | C145 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia
Program Materials Program Evaluations
03:30 PM - 03:35 PM PDT | Introduction |
Introduction/Opening Remarks
Meredith Wicklund, MD, FAAN |
03:30 PM - 03:30 PM PDT | Speaker |
Walk-in Slides
Meredith Wicklund, MD, FAAN |
03:35 PM - 04:10 PM PDT | Speaker |
Pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia
Lealani M. Acosta, MD, MPH, FAAN |
04:10 PM - 04:45 PM PDT | Speaker |
Non-pharmacologic Management of Cognitive and Behavioral Symptoms in Dementia
Julio C. Rojas-Martinez, MD, PhD |
04:45 PM - 05:20 PM PDT | Speaker |
Disease-modifying Treatment in Dementia
Meredith Wicklund, MD, FAAN |
05:20 PM - 05:30 PM PDT | Q&A |
Questions and Answers
Meredith Wicklund, MD, FAAN |
Meredith Wicklund, MD, FAAN | The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH. |
Lealani M. Acosta, MD, MPH, FAAN | Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Biohaven, Roche, NIH. |
Julio C. Rojas-Martinez, MD, PhD | The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. Dr. Rojas-Martinez has received research support from Roon, Healthcare. The institution of Dr. Rojas-Martinez has received research support from Amylyx. |